About
Gastrointestinal Therapeutics
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (31)
View allTotal Trials
31
As Lead Sponsor
28
As Collaborator
3
Total Enrollment
6,140
By Phase
PHASE3: 8PHASE2: 8PHASE4: 3PHASE1: 10PHASE2/PHASE3: 2
By Status
COMPLETED: 24RECRUITING: 4ACTIVE_NOT_RECRUITING: 1ENROLLING_BY_INVITATION: 1TERMINATED: 1
Clinical Trials Pipeline31 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06810167Collaborator
Assessing Tenapanor as a Treatment of CF-related Constipation.
PHASE3Recruiting
25 participants
Started: Jun 1, 2025 · Completed: Jun 30, 2027
NCT06460038Collaborator
Tenapanor in Synucleinopathy-Related Constipation
PHASE2Recruiting
30 participants
Started: Jan 1, 2025 · Completed: Mar 31, 2027
NCT06553547Lead Sponsor
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
PHASE2Recruiting
72 participants
Started: Jul 24, 2024 · Completed: Jun 30, 2026
NCT05995899Collaborator
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
PHASE4Active, not recruiting
30 participants
Started: Feb 6, 2024 · Completed: Oct 31, 2025
NCT06203444Lead Sponsor
An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females
PHASE1Completed
7 participants
Started: Nov 27, 2023 · Completed: May 30, 2024
Locations (1)
Headquarters
Fremont, CA, United States
Map
Loading map...